Kindbody

Kindbody offers fertility monitoring and preservation services through more than 300 locations, including their own clinics as well via a network of partner clinics with COE (center of excellence). Its clinics and online support network provide gynecology and wellness services including fertility assessments, egg freezing, embryo freezing, in vitro fertilization (IVF), and LGBTQ fertility consultation among others.

Kindbody launched its first consumer product— Kind at Home , and made its foray into the fertility test-kit market in January 2022. Kind at Home, which is a fertility hormone test kit for both women and men, is administered via a finger prick blood test. The test kit includes personalized recommendations by Kindbody’s board-certified physicians. The test kit for women determines levels of seven reproductive hormones relating to ovulatory function, infertility, miscarriage, and menopause to indicate ovarian reserve and female reproductive health. The test kit for men also determines levels of seven reproductive hormones including testosterone to indicate male reproductive function and sexual health. The test kit provides comprehensive information on fertility windows with personalized physician-led recommendations on overall reproductive health through in-clinic or virtual appointments within the patient portal.

Kindbody has expanded its own clinic network, having opened three in H1 2021, bringing its total to nine clinics as of June 2021, and is scheduled to open in 13 locations by the end of 2021. 

Following this Kindbody acquired Vios Fertility Institute and its chain of clinics in February 2022, which valued the company at USD 1.15 billion. The acquisition doubled Kindbody's national footprint to 26 clinics and Kindbody expects to expand this to 40 by the end of 2022. Kindbody and Vios Fertility Institute together performed nearly 10,000 fertility treatments and served thousands of patients in 2021, which they expected to double in 2022. In June 2022, Kindbody acquired Phosphorus Labs , a verticalized genetic testing platform providing clinical-grade genetic testing for genomic information access. The acquisition enabled Kindbody to incorporate genomics into patient care. 

In August 2022, Kindbody acquired Alternative Reproductive Resources (ARR) , a gestational surrogacy agency to add gestational surrogacy as part of its product offerings and the company will absorb ARR’s employees to its KindEOS division–its in-house egg and embryo donor program.

Key customers and partnerships

In addition to its vast range of services, the company works with employers to make fertility care more affordable to its employees.

- In January 2024, Kindbody became part of Accolade's Trusted Partner Ecosystem to offer comprehensive, clinically guided support throughout members' fertility and family-building journeys, backed by a cost savings performance guarantee. 

- In September 2023, Kindbody expanded its partnership with Rightway, focused on integrating its comprehensive fertility services into Rightway's care navigation platform, RightwayHub. The company also partnered with Quantum Health in July 2023, incorporating its reproductive healthcare services into Quantum Health's Comprehensive Care Solutions platform.